Effect of levetiracetam therapy on electrocardiographic parameters - 23/03/23
Abstract |
Aim |
The purpose of this study was to compare the electrocardiographic parameters before and at the sixth month of treatment of patients diagnosed with epilepsy and who were started on levetiracetam therapy.
Methods |
The files of 30 patients diagnosed with epilepsy and on levetiracetam therapy were examined in this study. Clinical findings, electroencephalography (EEG), cranial magnetic resonance imaging (MRI) and electrocardiography (ECG) data before and at the sixth month of treatment were recorded.
Results |
The patients’ mean age was 10.93 ± 3.74 (4–17) years; 16 (53.33%) patients were boys. In total, 13 (43.3%) were found to experience focal seizures, and 17 (56.7%) generalized epilepsy-type seizures. Comparison of the ECG parameters (PR interval, QTc, QT interval, and QRS duration) revealed a shortening in the PR interval and QTc values at the sixth month of treatment, although the changes were not statistically significant. No significant differences in terms of gender and epilepsy types were observed between the ECG parameters before treatment and at the sixth month (p > 0.05).
Conclusion |
In this study, levetiracetam was found to have no effect on ECG parameters.
Le texte complet de cet article est disponible en PDF.Keywords : Epilepsy, Levetiracetam, Electrocardiography
Plan
Vol 30 - N° 3
P. 149-152 - avril 2023 Retour au numéro
Article précédent
- Evaluation of catch-up growth in severe pediatric Hashimoto's hypothyroidism
- A. Vincent, C. Bouvattier, C. Teinturier, D. Rodrigue, K. Busiah, I. Olivier-Petit, H. Bony, P. Barat, B. Cammas, R. Coutant, A. Lienhardt, A. Linglart, A.-S. Lambert
- Factors linked to Staphylococcus aureus healthcare-associated infections among pediatric intensive care unit colonized patients
- Perrine See, Stéphane Bonacorsi, Artemis Toumazi, Catherine Doit, Jérôme Naudin, Maryline Chomton, Fleur Le Bourgeois, Marion Caseris, Patricia Mariani-Kurkdjian, Géraldine Poncelet, Guillaume Geslain, Stéphane Dauger, Michael Levy
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?